MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin
Completed
- Conditions
- Anticoagulation in Dialysis Patients
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 37
- Registration Number
- NCT00660946
Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Phase 1
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 7
- Registration Number
- NCT00658892
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Quitline Use in Surgical Patients
Not Applicable
Completed
- Conditions
- Tobacco Dependence
- Interventions
- Behavioral: Standard brief adviceBehavioral: Quitline intervention
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 300
- Registration Number
- NCT00656500
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery
Phase 4
Completed
- Conditions
- Perioperative Inflammatory Response
- Interventions
- Drug: PlaceboDrug: Simvastatin
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 61
- Registration Number
- NCT00656292
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Stage IV Renal Cell CancerThyroid Gland Medullary CarcinomaUnspecified Adult Solid Tumor, Protocol SpecificGastrinomaInsulinomaMetastatic Gastrointestinal Carcinoid TumorMetastatic PheochromocytomaRecurrent Gastrointestinal Carcinoid TumorStage III Neuroendocrine Carcinoma of the SkinStage IV Melanoma
- Interventions
- Drug: everolimusDrug: vatalanibOther: pharmacological studyOther: laboratory biomarker analysisProcedure: dynamic contrast-enhanced magnetic resonance imagingProcedure: ultrasound imaging
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 96
- Registration Number
- NCT00655655
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Acupuncture and Post-Operative Ileus
Not Applicable
Completed
- Conditions
- Ileus
- Interventions
- Other: AcupunctureOther: Sham acupuncture
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2011-03-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 107
- Registration Number
- NCT00655317
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Dynamic MRI Evaluation Post Operative Stapled Trans Anal Rectal Resection (STARR) Procedure
Completed
- Conditions
- Obstructive Defecation SyndromeOutlet Obstruction
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2010-05-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT00655382
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2012-03-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT00653757
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1
Completed
- Conditions
- Extrahepatic Bile Duct CancerAnal CancerCarcinoma of the AppendixGastric CancerGastrointestinal Carcinoid TumorEsophageal CancerGallbladder CancerGastrointestinal Stromal TumorLiver CancerPancreatic Cancer
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 7
- Registration Number
- NCT00654160
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer
Phase 1
Completed
- Conditions
- Peritoneal Cavity CancerOvarian Cancer
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 48
- Registration Number
- NCT00652691
© Copyright 2025. All Rights Reserved by MedPath